Ultrasound-guided Bilateral Dual Transversus Abdominis Plane (BD-TAP) Block: Description of a Novel Four-point Ultrasound-guided TAP Block Approach
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Postoperative Pain
- Sponsor
- Bispebjerg Hospital
- Enrollment
- 30
- Locations
- 1
- Primary Endpoint
- Pain VAS after the intervention compared to pre-intervention VAS
- Status
- Completed
- Last Updated
- 10 years ago
Overview
Brief Summary
A prospective study of 30 patients with severe postoperative pain following abdominal surgery, in which the dual TAP block technique has been used successfully to achieve pain relief. A description of ultrasound technique, effectiveness, duration and potential side effects of the pain treatment, with possible recommendations for future use.
Detailed Description
This prospective cohort study is designed to describe a novel ultrasound-guided bilateral dual transversus abdominis plane (BD-TAP) block and to evaluate the postoperative analgesic efficacy in a selection of patients having undergone major abdominal surgery under general anaesthesia where neuraxial anaesthesia and/or intravenous administration of analgesics had failed or was unwanted by the patient, or if the placement of an epidural catheter was deemed impossible by the anaesthetist in charge. 30 consecutive patients planned for the study. BD-TAP to be performed bilaterally with a high frequency linear ultrasound probe, with bupivacaine. Success rate, decline in VAS score, postoperative demand of opioids and block performance time to be recorded.
Investigators
Kenneth Jensen, MD, BBA
MD, BBA
Bispebjerg Hospital
Eligibility Criteria
Inclusion Criteria
- •Patients with pain VAS \>5 following abdominal surgery, in which conventional pain treatment or epidural block is either ineffective or contraindicated
Exclusion Criteria
- •Hypersensitivity to local anaesthetics
Outcomes
Primary Outcomes
Pain VAS after the intervention compared to pre-intervention VAS
Time Frame: 10-20 minutes after intervention
Secondary Outcomes
- Pain medication required following intervention(First 24 hours)